Short-term effect of scalpel debridement of plantar callosities versus treatment with salicylic acid patches: The EMEDESCA randomized controlled trial.
Gabriel Gijón-NoguerónIrene García-PayaJosé Miguel Morales-AsencioAna Jiménez-CebriánAna Belén Ortega-ÁvilaJosé Antonio Cervera-MarínPublished in: The Journal of dermatology (2016)
This study compares scalpel debridement versus salicylic acid patches in the treatment of plantar callosities. A randomized clinical trial (ACTRN12614000591651) was performed with 62 patients, divided into two intervention groups. Group A received treatment with salicylic acid patches (Callívoro Marthand® ) and group B underwent scalpel debridement of plantar callosities. Pain was measured on a visual analog scale, and foot pain and disability were evaluated using the Manchester Foot Pain Disability Index (MFPDI) questionnaire (Spanish version). Significant differences were observed in pain measured immediately after treatment (P < 0.001) and at 15 days and 6 weeks after treatment. For some components, the MFPDI questionnaire revealed significantly better outcomes by scalpel debridement at 15 days after treatment. The scalpel debridement of plantar callosities relieves pain more effectively than salicylic acid patches, and patients achieve greater functionality in the initial weeks after debridement.
Keyphrases
- chronic pain
- randomized controlled trial
- pain management
- end stage renal disease
- neuropathic pain
- ejection fraction
- newly diagnosed
- chronic kidney disease
- multiple sclerosis
- peritoneal dialysis
- clinical trial
- patient reported
- spinal cord
- cross sectional
- systematic review
- type diabetes
- patient reported outcomes
- weight loss
- preterm birth
- double blind